The primary purpose of this training grant program is the development of scientific leaders for careers in HIV/AIDS research. The current expanding epidemic of HIV infection demands commitment of investigators to the training of a new generation of leaders in research. It is anticipated that graduates of this postdoctoral program will follow careers in research related to AIDS. This program will provide in depth laboratory experience in a specific research area of virology, immunology, molecular biology, oncology, epidemiology molecular genetics, or molecular therapeutics to selected candidates. Trainees will be MDs after completion of their clinical residencies and specialty training or PhDs and ScDs from an appropriate basic science program. Criteria for selection will include prior training record, aptitude for research and commitment to research careers. All applicants will be selected by a Program Steering Committee, and six will be selected annually. Particular emphasis will be given to the recruitment of minorities and others underrepresented in AIDS research, e.g., women, individuals with disabilities, and those from disadvantaged backgrounds. The basic elements of the program are: 1) in depth research training through laboratory investigation of a specific problem in a particular area related to AIDS under a senior investigator;2) a didactic program consisting of appropriately chosen specific courses which will advance the trainee's knowledge;3) frequent exposure to seminars, workshops, and colloquia related to AIDS;4) regular review of progress by individual Progress Evaluation Committees and the Program Steering Committee. The primary training facilities consist of well equipped research laboratories at Harvard Medical School, Harvard School of Public Health, Massachusetts General Hospital, Beth Israel-Deaconess Medical Center, Brigham and Women's Hospital, the Immune Disease Institute, Dana-Farber Cancer Institute, the Ragon Institute and the New England Primate Research Center. Senior and Junior faculty at each of these institutions are on the faculty of this grant, and they represent a variety of disciplines. The faculty collaborates with one another on AIDS research and will collaborate in directing this training program.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Acquired Immunodeficiency Syndrome Research Review Committee (AIDS)
Program Officer
Sharma, Opendra K
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Massachusetts General Hospital
United States
Zip Code
K├Ârner, Christian; Granoff, Mitchell E; Amero, Molly A et al. (2014) Increased frequency and function of KIR2DL1-3? NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes. Eur J Immunol 44:2938-48
Vaidya, Sagar A; Korner, Christian; Sirignano, Michael N et al. (2014) Tumor necrosis factor ? is associated with viral control and early disease progression in patients with HIV type 1 infection. J Infect Dis 210:1042-6
Penaloza-MacMaster, Pablo; Teigler, Jeffrey E; Obeng, Rebecca C et al. (2014) Augmented replicative capacity of the boosting antigen improves the protective efficacy of heterologous prime-boost vaccine regimens. J Virol 88:6243-54
Yen, Po-Jen; Herschhorn, Alon; Haim, Hillel et al. (2014) Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission. J Virol 88:5014-28
Carlson, Jonathan M; Schaefer, Malinda; Monaco, Daniela C et al. (2014) HIV transmission. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science 345:1254031
Fackler, Oliver T; Murooka, Thomas T; Imle, Andrea et al. (2014) Adding new dimensions: towards an integrative understanding of HIV-1 spread. Nat Rev Microbiol 12:563-74
Teigler, Jeffrey E; Penaloza-MacMaster, Pablo; Obeng, Rebecca et al. (2014) Hexon hypervariable region-modified adenovirus type 5 (Ad5) vectors display reduced hepatotoxicity but induce T lymphocyte phenotypes similar to Ad5 vectors. Clin Vaccine Immunol 21:1137-44
McGee, Kathleen; Haim, Hillel; Korioth-Schmitz, Birgit et al. (2014) The selection of low envelope glycoprotein reactivity to soluble CD4 and cold during simian-human immunodeficiency virus infection of rhesus macaques. J Virol 88:21-40
Murooka, Thomas T; Mempel, Thorsten R (2013) Intravital microscopy in BLT-humanized mice to study cellular dynamics in HIV infection. J Infect Dis 208 Suppl 2:S137-44
Khoury, Michael N; Gheuens, Sarah; Ngo, Long et al. (2013) Hyperperfusion in progressive multifocal leukoencephalopathy is associated with disease progression and absence of immune reconstitution inflammatory syndrome. Brain 136:3441-50

Showing the most recent 10 out of 41 publications